In prodromal AD, tau PET was slightly stronger associated with lower scores on cognitive tests than amyloid PET and cortical thickness, suggesting that tau PET is more sensitive than amyloid PET/cortical thickness in measuring cognitive changes early in the disease [93]. This evidence concerns the gene MAPT and Alzheimer disease.